Back to Search Start Over

Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis.

Authors :
Jarde A
Lutsiv O
Beyene J
McDonald SD
Source :
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2019 Apr; Vol. 126 (5), pp. 556-567. Date of Electronic Publication: 2018 Dec 29.
Publication Year :
2019

Abstract

Background: Recent progesterone trials call for an update of previous syntheses of interventions to prevent preterm birth.<br />Objectives: To compare the relative effects of different types and routes of administration of progesterone, cerclage, and pessary at preventing preterm birth in at-risk women overall and in specific populations.<br />Search Strategy: We searched Medline, EMBASE, CINAHL, Cochrane CENTRAL, and Web of Science up to 1 January 2018.<br />Selection Criteria: We included randomised trials of progesterone, cerclage or pessary for preventing preterm birth in at-risk singleton pregnancies.<br />Data Collection and Analysis: We used a piloted data extraction form and performed Bayesian random-effects network meta-analyses with 95% credibility intervals (CrI), as well as pairwise meta-analyses, rating the quality of the evidence using GRADE.<br />Main Results: We included 40 trials (11 311 women). In at-risk women overall, vaginal progesterone reduced preterm birth <34 (OR 0.43, 95% CrI 0.20-0.81) and <37 weeks (OR 0.51, 95% CrI 0.34-0.74), and neonatal death (OR 0.41, 95% CrI 0.20-0.83). In women with a previous preterm birth, vaginal progesterone reduced preterm birth <34 (OR 0.29, 95% CI 0.12-0.68) and <37 weeks (OR 0.43, 95% CrI 0.23-0.74), and 17α-hydroxyprogesterone caproate reduced preterm birth <37 weeks (OR 0.53, 95% CrI 0.27-0.95) and neonatal death (OR 0.39, 95% CI 0.16-0.95). In women with a short cervix (≤25 mm), vaginal progesterone reduced preterm birth <34 weeks (OR 0.45, 95% CI 0.24-0.84).<br />Conclusions: Vaginal progesterone was the only intervention with consistent effectiveness for preventing preterm birth in singleton at-risk pregnancies overall and in those with a previous preterm birth.<br />Tweetable Abstract: In updated NMA, vaginal progesterone consistently reduced PTB in overall at-risk pregnancies and in women with previous PTB.<br /> (© 2018 Royal College of Obstetricians and Gynaecologists.)

Details

Language :
English
ISSN :
1471-0528
Volume :
126
Issue :
5
Database :
MEDLINE
Journal :
BJOG : an international journal of obstetrics and gynaecology
Publication Type :
Academic Journal
Accession number :
30480871
Full Text :
https://doi.org/10.1111/1471-0528.15566